Loading chat...
NJ A4082
Bill
Status
2/19/2026
Primary Sponsor
Annette Quijano
Click for details
AI Summary
-
Establishes a registration and regulatory framework for hemp-derived cannabinoid products (including Delta-8-THC and other psychoactive cannabinoids) sold in New Jersey, administered by the Cannabis Regulatory Commission.
-
Requires manufacturers and retailers of hemp-derived cannabinoid products to register with a state database and pay registration fees to fund program operations.
-
Prohibits sale of hemp-derived cannabinoid products with detectable THC to persons under 21 years of age, requiring government-issued photo identification verification before purchase.
-
Mandates comprehensive labeling requirements including THC content percentages, serving sizes, ingredient lists, allergen warnings, production dates, and health warnings about intoxication effects and risks during pregnancy.
-
Requires child-resistant, opaque packaging and prohibits marketing that appeals to minors, promotes overconsumption, or uses cartoon characters or toys in branding.
Legislative Description
Requires registration and regulation of certain hemp-derived cannabinoids manufactured and sold in this State.
Oversight, Reform and Federal Relations
Last Action
Introduced, Referred to Assembly Oversight, Reform and Federal Relations Committee
2/19/2026